Article
Population and family data support TNNT2 p.Arg288Cys as an intermediate effect variant in hypertrophic cardiomyopathy.
International journal of cardiology - 1 Jun 2026
Spanjersberg Talitha C F, Hassanzada Fahima, Jongbloed Jan D H, Dooijes Dennis, van Tintelen J Peter, Asselbergs Folkert W, van der Harst Pim, van Steenbeek Frank G, Harakalova Magdalena, van Spaendonck-Zwarts Karin Y, van Vugt Marion
Abstract excerpt
BACKGROUND: The TNNT2 (NM_001276345.2):c.862C>T, p.Arg288Cys variant has conflicting pathogenicity classifications. It is reported in individuals with severe hypertrophic cardiomyopathy (HCM) yet also occurs in the general population at a frequency challenging its presumed pathogenicity and creating uncertainty for genetic counseling. Therefore, the aim of this study was to evaluate its clinical relevance....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
